BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28291903)

  • 1. Prostate volume index stratified prostate cancer risk in patients elected to a first random biopsy set.
    Porcaro AB; Corsi P; de Luyk N; Sebben M; Tafuri A; Bizzotto L; Cacciamani G; De Marchi D; Processali T; Mattevi D; Novella G; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Tumori; 2017 Jul; 103(4):374-379. PubMed ID: 28291903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set.
    Porcaro AB; Novella G; Cacciamani G; De Marchi D; Corsi P; De Luyk N; Bizzotto L; Processali T; Cerasuolo M; Tamanini I; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Urol Int; 2017; 98(1):22-27. PubMed ID: 27376763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set.
    Porcaro AB; Novella G; de Luyk N; Corsi P; Cacciamani G; Sebben M; Tafuri A; Processali T; Cerasuolo M; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Tumori; 2017 Sep; 103(5):475-482. PubMed ID: 27834470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Volume Index Is Able to Differentiate between Prostatic Chronic Inflammation and Prostate Cancer in Patients with Normal Digital Rectal Examination and Prostate-Specific Antigen Values <10 ng/mL: Results of 564 Biopsy Naïve Cases.
    Porcaro AB; Tafuri A; Sebben M; Novella G; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Panunzio A; De Michele M; Brunelli M; Cerruto MA; Migliorini F; Siracusano S; Artibani W
    Urol Int; 2019; 103(4):415-422. PubMed ID: 31466070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate volume index and chronic inflammation of the prostate type IV with respect to the risk of prostate cancer.
    Porcaro AB; Novella G; Molinari A; Terrin A; Minja A; De Marco V; Martignoni G; Brunelli M; Cerruto MA; Curti P; Cavalleri S; Artibani W
    Urol Int; 2015; 94(3):270-85. PubMed ID: 25170543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set.
    Porcaro AB; Tafuri A; Novella G; Sebben M; Mariotto A; Inverardi D; Corsi P; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Brunelli M; Balzarro M; Siracusano S; Artibani W
    Urol Int; 2018; 100(4):456-462. PubMed ID: 29672311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
    Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
    BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy.
    García-Cruz E; Carrión Puig A; García-Larrosa A; Sallent A; Castañeda-Argáiz R; Piqueras M; Ribal MJ; Leibar-Tamayo A; Romero-Otero J; Alcaraz A
    Scand J Urol; 2013 Aug; 47(4):282-9. PubMed ID: 23181478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients.
    Porcaro AB; Tafuri A; Sebben M; Novella G; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Brunelli M; Cerruto MA; Migliorini F; Siracusano S; Artibani W
    Int Braz J Urol; 2020; 46(4):545-556. PubMed ID: 32213210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population.
    Wang Y; Xie S; Shangguan X; Pan J; Zhu Y; Xin Z; Xu F; Shao X; Fan L; Sha J; Liu Q; Dong B; Xue W
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1157-1166. PubMed ID: 28283782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy.
    Porcaro AB; Tafuri A; Sebben M; Novella G; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Mariotto A; Brunelli M; Cerruto MA; Cacciamani GE; Migliorini F; Siracusano S; Artibani W
    World J Urol; 2020 Apr; 38(4):957-964. PubMed ID: 31154465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.
    Roobol MJ; van Vugt HA; Loeb S; Zhu X; Bul M; Bangma CH; van Leenders AG; Steyerberg EW; Schröder FH
    Eur Urol; 2012 Mar; 61(3):577-83. PubMed ID: 22104592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.
    Ploussard G; Nicolaiew N; Marchand C; Terry S; Allory Y; Vacherot F; Abbou CC; Salomon L; de la Taille A
    BJU Int; 2013 May; 111(6):988-96. PubMed ID: 23452046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The digital rectal examination (DRE) remains important - outcomes from a contemporary cohort of men undergoing an initial 12-18 core prostate needle biopsy.
    Palmerola R; Smith P; Elliot V; Reese CT; Mahon FB; Harpster LE; Icitovic N; Raman JD
    Can J Urol; 2012 Dec; 19(6):6542-7. PubMed ID: 23228289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.
    Kader AK; Liss MA; Trottier G; Kim ST; Sun J; Zheng SL; Chadwick K; Lockwood G; Xu J; Fleshner NE
    Urology; 2015 Jan; 85(1):165-70. PubMed ID: 25530379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume.
    Chiu PK; Roobol MJ; Teoh JY; Lee WM; Yip SY; Hou SM; Bangma CH; Ng CF
    Int Urol Nephrol; 2016 Oct; 48(10):1631-7. PubMed ID: 27349564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
    Doluoglu OG; Ceylan C; Kilinc F; Gazel E; Resorlu B; Odabas O
    Int Braz J Urol; 2016; 42(2):346-50. PubMed ID: 27256190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.